Cytokinetics (CYTK)
NASDAQ:CYTK
Holding CYTK?
Track your performance easily

Cytokinetics (CYTK) Financial Statements

991 Followers

Cytokinetics Financial Overview

Cytokinetics's market cap is currently ―. The company's EPS TTM is $-5.371; its P/E ratio is -10.41; Cytokinetics is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-1.24. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 249.00K$ 835.00K$ 1.67M$ 378.00K$ 867.00K
Gross Profit$ -79.35M$ -80.73M$ -162.72M$ 378.00K$ 867.00K
EBIT$ -119.02M$ -118.32M$ -119.83M$ -115.43M$ -115.27M
EBITDA$ -116.61M$ -115.99M$ -113.50M-$ -117.28M
Net Income Common Stockholders$ -143.32M$ -135.64M$ -136.90M$ -129.42M$ -128.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.06B$ 618.96M$ 614.82M$ 539.24M$ 565.72M
Total Assets$ 1.52B$ 808.08M$ 824.32M$ 740.61M$ 779.90M
Total Debt$ 239.58M$ 205.13M$ 206.78M$ 200.34M$ 202.02M
Net Debt$ -817.20M$ -413.83M$ -408.04M$ -338.90M$ -363.70M
Total Liabilities$ 1.42B$ 1.20B$ 1.21B$ 1.18B$ 1.11B
Stockholders Equity$ 108.55M$ -396.16M$ -386.32M$ -438.80M$ -333.12M
Cash Flow-
Free Cash Flow$ -101.23M$ -129.50M$ -74.11M-$ -122.52M
Operating Cash Flow$ -99.32M$ -129.50M$ -74.04M$ -96.20M$ -121.81M
Investing Cash Flow$ -651.55M$ 32.64M$ -81.41M$ 73.04M$ 82.13M
Financing Cash Flow$ 821.01M$ 103.79M$ 168.80M$ 54.22M$ 5.47M
Currency in USD

Cytokinetics Earnings and Revenue History

Cytokinetics Debt to Assets

Cytokinetics Cash Flow

Cytokinetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis